NCT06267326已完成1 期
Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt
Nasser Institute For Research and Treatment1 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2021年5月23日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- pain
研究概览
简要总结
Objectives: identify and recognize clinical Characteristics, Pathophysiology, and management of a group of patients with rhino Rhino-Orbito-Cerebral Mucormycosis infection associated with Covid 19 viral infection
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Single (Care Provider)
入排标准
- 年龄范围
- 22 Years 至 77 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •all patients with mucormycosis post covid 19
排除标准
- •The patient not suffered from covid 19
结局指标
主要结局
pain
时间窗: two years
Visual Analog Score for pain
35 patients suffering from mucormycosis infection post covid 19
时间窗: 2 years
Ratio Scale. Visual Analog Score for pain Ratio Scale. Ratio Scale. ratio scale
25 patients were cured with comorbidity and 10 pateints died
时间窗: 2 years
ordinal scale Visual Analog Score for pain
次要结局
- Visual Analog Score for pain(2years)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Risk factors for Mucormycosis following COVID-19CTRI/2021/07/034743Dr P Manickam
已完成
不适用
Perioperative outcome of Covid-19 associated MucormycosisCTRI/2021/07/034665All India Institute of Medical Sciences Raipur52
Unknown
不适用
Neurologic Manifestations of COVID-19Coronavirus Disease 2019NCT04386083University of the Philippines1,342
已完成
不适用
COVID19 Neurological ManifestationSARS-CoV 2Neurologic ManifestationsNCT04496128University of Pittsburgh300
Unknown
不适用
Neuroradiolological Analysis of COVID-19 PatientsCovid-19NCT04368390University Hospital, Strasbourg, France100